These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 37671163)

  • 41. Percutaneous cryoablation for the treatment of medically inoperable stage I non-small cell lung cancer.
    Yamauchi Y; Izumi Y; Hashimoto K; Yashiro H; Inoue M; Nakatsuka S; Goto T; Anraku M; Ohtsuka T; Kohno M; Kawamura M; Nomori H
    PLoS One; 2012; 7(3):e33223. PubMed ID: 22413004
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The future of cryoablation: An abscopal effect.
    Chen J; Qian W; Mu F; Niu L; Du D; Xu K
    Cryobiology; 2020 Dec; 97():1-4. PubMed ID: 32097610
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined therapy of percutaneous cryoablation and traditional Chinese medicine can be a promising strategy for elderly or advanced lung cancer patients based on a retrospective clinical study.
    Gao L; Li Q; Jiang M; Liu C; Song Z; Bao X; Shen Y; Liu G; Hu K
    Cryobiology; 2014 Aug; 69(1):174-7. PubMed ID: 24859157
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cryoablation of early-stage primary lung cancer.
    Inoue M; Nakatsuka S; Jinzaki M
    Biomed Res Int; 2014; 2014():521691. PubMed ID: 24991559
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Retrospect and Prospect for Lung Cancer in China: Clinical Advances of Immune Checkpoint Inhibitors.
    Lu S; Yu Y; Yang Y
    Oncologist; 2019 Feb; 24(Suppl 1):S21-S30. PubMed ID: 30819828
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Progress, Challenges, and Prospects.
    Tang S; Qin C; Hu H; Liu T; He Y; Guo H; Yan H; Zhang J; Tang S; Zhou H
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159131
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional tumor cell-intrinsic STING, not host STING, drives local and systemic antitumor immunity and therapy efficacy following cryoablation.
    Alshebremi M; Tomchuck SL; Myers JT; Kingsley DT; Eid S; Abiff M; Bonner M; Saab ST; Choi SH; Huang AY
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37553183
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic outcomes of combining cryotherapy, chemotherapy and DC-CIK immunotherapy in the treatment of metastatic non-small cell lung cancer.
    Yuanying Y; Lizhi N; Feng M; Xiaohua W; Jianying Z; Fei Y; Feng J; Lihua H; Jibing C; Jialiang L; Kecheng X
    Cryobiology; 2013 Oct; 67(2):235-40. PubMed ID: 23948179
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Investigation of the efficacy and safety of cryoablation and intra-arterial PD-1 inhibitor in patients with advanced disease not responding to checkpoint inhibitors: An exploratory study.
    Wei F; Guo R; Yan Y; Lin R; Chen J; Lin Z
    Front Immunol; 2022; 13():990224. PubMed ID: 36211329
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lung cancer immunotherapy: progress, pitfalls, and promises.
    Lahiri A; Maji A; Potdar PD; Singh N; Parikh P; Bisht B; Mukherjee A; Paul MK
    Mol Cancer; 2023 Feb; 22(1):40. PubMed ID: 36810079
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The next generation of immunotherapy: keeping lung cancer in check.
    Somasundaram A; Burns TF
    J Hematol Oncol; 2017 Apr; 10(1):87. PubMed ID: 28434399
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Progress in the cryoablation and cryoimmunotherapy for tumor.
    Chen Z; Meng L; Zhang J; Zhang X
    Front Immunol; 2023; 14():1094009. PubMed ID: 36761748
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combination Strategies on the Basis of Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer: Where Do We Stand?
    Qiao M; Jiang T; Ren S; Zhou C
    Clin Lung Cancer; 2018 Jan; 19(1):1-11. PubMed ID: 28716463
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical study of cryoablation in the salvage treatment of stage III non-small cell lung cancer].
    Li Y; Guo Z; Wang HT; Liu F; Ni H
    Zhonghua Yi Xue Za Zhi; 2011 Aug; 91(31):2205-7. PubMed ID: 22094040
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combining immunotherapies to treat non-small cell lung cancer.
    Spagnuolo A; Gridelli C
    Expert Rev Respir Med; 2019 Jul; 13(7):621-634. PubMed ID: 31116072
    [No Abstract]   [Full Text] [Related]  

  • 56. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
    Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [TACE with Ar-He cryosurgery combined minimal invasive technique for the treatment of primary NSCLC in 139 cases].
    Luo L; Wang H; Ma H; Zou H; Li D; Zhou Y
    Zhongguo Fei Ai Za Zhi; 2010 Jan; 13(1):60-3. PubMed ID: 20672706
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
    Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
    JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cryoablation is superior to radiofrequency ablation for the treatment of non-small cell lung cancer: A meta-analysis.
    Xu Z; Wang X; Ke H; Lyu G
    Cryobiology; 2023 Sep; 112():104560. PubMed ID: 37499964
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cryoablation for advanced non-small cell lung cancer: a protocol for a systematic review.
    Duan H; Zheng SY; Luo C; Fang X; Wang D; Pang H; Wang M; Chen Y; Zhou T; Li Q; Hu K
    BMJ Open; 2020 Sep; 10(9):e033460. PubMed ID: 32895259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.